StockpollyBeta
Get App
Delisting riskPopularity #5,333
KPRX · NASDAQ · Biotechnology

Kiora Pharmaceuticals (KPRX)

Develops intravitreal photoswitch and DHODH-inhibitor candidates for retinal degeneration and inflammation.

$2.76
After hours+0.02 (+0.73%)
At close$2.74(+2.24%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Insiders2.64%116.7K shares
4 holders · as of Jul 2, 2026
Strategic holders18.70%827.2K shares
2 holders · as of Feb 11, 2026
Other78.66%3.48M shares
remainder

4.42M company shares as of Sep 22, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Rosalind Advisors, Inc.Strategic
10.50%464,676filed Feb 11, 2026
Perceptive Advisors LLCInstitution
10.00%442,387filed Aug 10, 2026
Nantahala Capital Management, LLCInstitution
9.91%438,469filed May 15, 2026
Alyeska Investment Group, L.P.Institution
8.92%394,668filed May 15, 2026
ADAR1 Capital Management, LLCStrategic
8.19%362,527filed Aug 14, 2025
Baselake Partners, LPInstitution
5.82%257,500filed Sep 17, 2026
Brian M. StremInsiderdirector, officer: President and CEO
1.33%58,823filed Jul 2, 2026
Eric Joseph DanielsInsiderofficer: Chief Development Officer
0.72%31,741filed Apr 2, 2026
Melissa ToscaInsiderofficer: CFO
0.59%26,064filed Jul 2, 2026
Jonathan LauInsider
0.00%44filed Jan 27, 2020
ADAR1 Capital Management GP, LLCStrategic
—9.99% of class, as filed—filed Nov 14, 2024
Empery Asset Management, LPInstitution
—9.22% of class, as filed—filed Jun 14, 2017
Lincoln Park Capital Fund, LLCStrategic
—9.99% of class, as filed—filed Jul 28, 2022
Lind Global Fund II LPInstitution
—9.90% of class, as filed—filed Jun 13, 2023
Michael BiggerInsider
—6.30% of class, as filed—filed Aug 19, 2021
Mitchell P. KopinInsider
—9.99% of class, as filed—filed Aug 1, 2022
NPE Coinvest 1Insider
—3.60% of class, as filed—filed Jun 16, 2017
Rosalind Master Fund L.P.Institution
—9.90% of class, as filed—filed May 29, 2024
Thomas BallandInsider
—9.60% of class, as filed—filed Jun 16, 2017
Timothy P. LynchInsider
—11.00% of class, as filed—filed Feb 9, 2024
Erin Parsons1Insiderdirector
0.12%5,260filed Jun 13, 2024
Praveen Tyle2Insiderdirector
0.11%5,014filed Aug 19, 2024
Aron Shapiro3Insiderdirector
0.07%3,000filed Sep 11, 2024
Armistice Capital, LLC4Strategic10 percent owner
0.05%2,181filed Aug 3, 2021
Carmine N. Stengone5Insiderdirector
0.03%1,250filed Sep 12, 2024
  1. Last filed Jun 13, 2024; leaving the company requires no filing. Not in the bar.
  2. Last filed Aug 19, 2024; leaving the company requires no filing. Not in the bar.
  3. Last filed Sep 11, 2024; leaving the company requires no filing. Not in the bar.
  4. Last filed Aug 3, 2021; leaving the company requires no filing. Not in the bar.
  5. Last filed Sep 12, 2024; leaving the company requires no filing. Not in the bar.

13F

No 13F holders on record.

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Perceptive Advisors LLC9.99%442.4K13GAug 10, 2026
Alyeska Investment Group, L.P.9.99%394.7K13GMay 15, 2026
Nantahala Capital Management, LLC9.99%438.5K13GMay 15, 2026
ADAR1 Capital Management GP, LLCincl. Daniel Schneeberger, ADAR1 Capital Management, LLC9.99%315.1K13GNov 14, 2024
Rosalind Advisors, Inc.9.90%464.7K13GFeb 11, 2026
ADAR1 Capital Management, LLC9.90%362.5K13GAug 14, 2025
Alyeska Fund GP, LLCincl. Anand Parekh, Alyeska Investment Group, L.P.8.40%256.4KNov 14, 2024
Goldman Sachs & Co. LLCincl. The Goldman Sachs Group, Inc.6.10%180.8KNov 12, 2024
Baselake Partners, LP5.80%257.5K13GSep 17, 2026

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.